Dario A. A. Vignali,Seng-ryong Woo,Greg M. Delgoffe
申请号：
US15361839
公开号：
US20170137524A1
申请日:
2016.11.28
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The invention is directed to treatment of cancer, infections and various inflammatory and autoimmune conditions by affecting regulatory T cell stability and function via a Neuropilin-1:Semaphorin axis.
